Marc Fischer Memorial Act
- Bill Number
- H.R. 1046
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-02-06: Referred to the House Committee on the Judiciary.
- Last Updated
- 2026-05-30T08:05:53Z
AI-Generated Summary
Purpose
The legislation, titled the "Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act" (or "Marc Fischer Memorial Act"), aims to enhance the safety of federal correctional facilities by requiring the Bureau of Prisons (BOP) to develop and implement a comprehensive strategy to detect and prevent the entry of fentanyl and other synthetic drugs through inmate mail. It addresses the growing threat of drug smuggling via mail, which contributes to overdoses and endangers staff and inmates.
Key Provisions
- Evaluation Phase: Within 180 days of enactment, the BOP Director must assess current and potential technologies for detecting synthetic drugs in mail, including equipment acquisition, scanning services, and tools used by other federal, state, or local agencies.
- Strategy Development: Within 90 days after the evaluation, the Director must submit a detailed strategy to the Senate and House Judiciary Committees. The strategy must:
- Protect staff and inmates from drug exposure via mail.
- Ensure inmates receive a digital copy of their mail within 24 hours of arrival (at the facility or an offsite contractor), and the original physical copy within 30 days if it is free of synthetic drugs or opioids (with delivery documented).
- Establish processes for handling legal mail, including sender verification while preserving attorney-client privilege (a legal protection that keeps communications between lawyers and clients confidential).
- Achieve 100% scanning of all incoming mail at federal facilities.
- Strategy Contents: The plan must identify necessary information technology, scanning equipment, and services; evaluate operational needs (e.g., prioritizing high-security facilities, staff training, and maintenance); and include a budget proposal for fiscal years 2025–2027.
- Implementation and Reporting: Full implementation must occur within 3 years of strategy submission, subject to available funding. Annual reports to Congress are required starting one year after submission, detailing the strategy's effectiveness and quantities of detected drugs.
Significant Changes to Existing Law
This bill introduces new mandatory requirements for the BOP, including a nationwide strategy for digital mail scanning and 100% mail interdiction, building on a limited pilot program (conducted in 2020–2021 at two facilities) that showed promise but was not scaled up. It shifts some mail processing duties away from BOP staff to offsite or contracted services, potentially reducing their workload. Previously, there was no federal law mandating such comprehensive, technology-driven mail screening across all BOP facilities, though general authority exists for contraband control.
Potential Impacts
- Government Agencies: The BOP, which oversees 122 facilities and 150,000+ inmates, will face initial costs for technology and training but could gain long-term budgetary relief by outsourcing mail sorting and reducing staff reassignments. This may ease staffing shortages amid rising workloads.
- Citizens: Federal inmates will benefit from safer environments with fewer drug-related incidents (e.g., a noted 600% rise in overdoses), though they may experience delays in receiving physical mail. BOP employees (nearly 38,000) will be better protected from accidental exposure to laced mail.
- International Relations: Minimal direct impact, as the focus is domestic prison operations; however, it indirectly supports U.S. efforts to combat the broader fentanyl crisis, which often involves international supply chains.
Main Stakeholders Affected
- Bureau of Prisons (BOP): Primary implementer, responsible for evaluation, strategy, and rollout.
- Federal Inmates and Staff: Direct beneficiaries through reduced drug exposure and improved safety; inmates may adapt to digital mail formats.
- Congressional Judiciary Committees: Oversee submission and reporting.
- Families and Correspondents of Inmates: Affected by changes in mail delivery processes.
- Technology Providers and Contractors: Potential suppliers of scanning equipment and offsite mail services.
- Legal Professionals: Ensured continued protections for privileged communications.
Notable Legal, Constitutional, or Political Implications
- Legal: Reinforces existing anti-contraband laws under the Controlled Substances Act by targeting synthetic drugs (defined as fentanyl analogues or similar controlled substances). It mandates safeguards for attorney-client privilege, avoiding broad privacy intrusions, but could face challenges if scanning processes are seen as overly invasive (though the bill emphasizes verification only for legal mail).
- Constitutional: Aligns with the government's authority to regulate prisons for security (under the Eighth Amendment's prohibition on cruel and unusual punishment), potentially reducing overdose deaths that could be viewed as unconstitutional conditions of confinement. No direct conflicts with First Amendment mail rights, as digital delivery maintains access.
- Political: Bipartisan sponsorship (from both parties) highlights consensus on addressing the prison drug crisis amid national opioid concerns. It promotes evidence-based solutions via pilot data, but implementation depends on appropriations, which could spark debates over federal spending priorities in corrections.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (135)
Rep. Horsford, Steven [D-NV-4], Rep. Moore, Barry [R-AL-1], Rep. Moskowitz, Jared [D-FL-23], Rep. Miller, Carol D. [R-WV-1], Rep. Pappas, Chris [D-NH-1], Rep. Weber, Randy K. Sr. [R-TX-14], Rep. Cuellar, Henry [D-TX-28], Rep. Lieu, Ted [D-CA-36], Rep. Meuser, Daniel [R-PA-9], Rep. Neguse, Joe [D-CO-2], Rep. De La Cruz, Monica [R-TX-15], Rep. Van Duyne, Beth [R-TX-24], Rep. Harder, Josh [D-CA-9], Rep. Ciscomani, Juan [R-AZ-6], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Rep. Carbajal, Salud O. [D-CA-24], Rep. Flood, Mike [R-NE-1], Rep. Davis, Donald G. [D-NC-1], Rep. Perez, Marie Gluesenkamp [D-WA-3], Rep. Rutherford, John H. [R-FL-5], Rep. Stauber, Pete [R-MN-8], Rep. Lee, Susie [D-NV-3], Rep. Deluzio, Christopher R. [D-PA-17], Rep. Aderholt, Robert B. [R-AL-4], Rep. Sorensen, Eric [D-IL-17], Rep. Panetta, Jimmy [D-CA-19], Rep. Carey, Mike [R-OH-15], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Valadao, David G. [R-CA-22], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Rogers, Harold [R-KY-5], Rep. Landsman, Greg [D-OH-1], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Bost, Mike [R-IL-12], Rep. McDowell, Addison [R-NC-6], Rep. Van Orden, Derrick [R-WI-3], Rep. Veasey, Marc A. [D-TX-33], Rep. Wilson, Joe [R-SC-2], Rep. Smith, Christopher H. [R-NJ-4], Rep. Pettersen, Brittany [D-CO-7], Rep. Rogers, Mike D. [R-AL-3], Rep. Gottheimer, Josh [D-NJ-5], Rep. Messmer, Mark [R-IN-8], Rep. Riley, Josh [D-NY-19], Rep. Tenney, Claudia [R-NY-24], Rep. Obernolte, Jay [R-CA-23], Rep. Garbarino, Andrew R. [R-NY-2], Rep. Smith, Adrian [R-NE-3], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Bilirakis, Gus M. [R-FL-12] and 85 more
Recent Actions
- 2025-02-06: Referred to the House Committee on the Judiciary.
- 2025-02-06: Introduced in House
- 2025-02-06: Introduced in House
Bill Versions
- Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act — issued 2025-02-06 — PDF (7 pages)